Statin Use Linked to Improved Survival in Advanced Prostate Cancer Patients on Hormone Therapy

[Samrecan]

A systematic review and meta-analysis published in JAMA Network Open examined the association between statin use and mortality among men undergoing androgen-ablative therapies for advanced prostate cancer. The analysis included 12 studies with a total of 87,346 patients. Findings indicated that postdiagnostic statin use was associated with a 27% reduction in overall mortality and a 24% reduction in prostate cancer–specific mortality. These results suggest that statin use may improve survival outcomes in this patient population

jamanetwork.com/journals/ja...